FDA raps AstraZeneca for off-label Seroquel promotion
Anthony Vecchione
December 05 2008
The FDA's DDMAC issued a warning letter to AstraZeneca asserting that a company sales rep recommended or suggested to a ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.